Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
FDA Approval
Sort By
Newest First
1 / 15
Drug Approvals
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Pharma's Almanac
PAO-03-25-RT-01
Mar 26, 2025
Boehringer Ingelheim Pharmaceuticals, Inc.
FDA
Boehringer's Zongertinib ReceivesFDA Priority Review for the Treatment of HER2 (ERBB2)- NSCLC
Boehringer Ingelheim Pharmaceuticals, Inc.
PR-02-25-NI-21
Feb 20, 2025
Roche
FDA
Roche Receives FDA 510(k) Clearance for the First Blood Test in the U.S. Measuring Lp(a) in Nolar Units
Roche
PR-01-25-NI-29
Feb 11, 2025
Clarity
FDA
Clarity Receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in Biochemical Recurrence of Prostate Cancer
Clarity
PR-01-25-NI-25
Jan 24, 2025
UCB
CDMO
UCB Announces FDA Approvals for BIMZELX for Psoriatic Arthritis, Axial Spondyloarthritis, and Ankylosing Spondylitis
UCB
PR-09-24-NI-13
Sep 23, 2024
Actinium Pharmaceuticals, Inc.
Clinical Result
Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in Clinical Oncology
Actinium Pharmaceuticals, Inc.
PR-09-24-NI-09
Sep 20, 2024
Expansion
Building on a Pioneering Biomanufacturing Legacy with Client Centricity
Benedikt von Braunmühl; Tom Roberts
Rentschler Biopharma SE
PAO-09-24-CL-05
Sep 09, 2024
Lamassu Biotech
FDA Approval
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol
Lamassu Biotech
PR-M04-24-01
Apr 19, 2024
FDA New Drug Approvals
Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-23-NI-03
Mar 07, 2023
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06
Jul 02, 2022
Column: New Drug Watch
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-08
Jun 24, 2022
Column: New Drug Watch
Alzheimer Drug Still Controversial
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-022-NI-04
Mar 23, 2022
Brand Institute
COVID-19 Vaccine
FDA Approves SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine
Brand Institute
PR-M02-22-01
Feb 01, 2022
Biogen
FDA Approval
FDA Grants Accelerated Approval for Aduhelm™ as the First and Only Alzheimer’s Disease Treatment to Address a Defining Pathology of the Disease
Biogen
PR-M06-21-015
Jun 08, 2021
Bristol-Myers Squibb
FDA Approval
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Zeposia® (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis
Bristol-Myers Squibb
PR-M06-21-008
Jun 07, 2021
Novartis
FDA Approval
Novartis Cosentyx Receives FDA Approval for Treatment of Children and Adolescents with Moderate to Severe Plaque Psoriasis
Novartis
PR-M06-21-002
Jun 01, 2021
Blueprint Medicines
FDA Approval
Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
Blueprint Medicines
PR-M11-20-027
Dec 02, 2020
Eli Lilly and Company
Antibodies
Lilly's Neutralizing Antibody Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization for the Treatment of Recently Diagnosed COVID-19
Eli Lilly and Company
PR-M11-20-023
Dec 01, 2020
U.S. Food & Drug Administration
FDA Approval
FDA Approves First Treatment for Ebola Virus
U.S. Food & Drug Administration
PR-M10-20-10
Oct 15, 2020
Trevena
Opioid
Trevena Announces FDA Approval of OLINVYK Injection
Trevena
PR-M08-20-NI-30
Aug 18, 2020
1 / 15
